Article

Immune Checkpoint Inhibitors in Patients with Cancer and Chronic Kidney Disease: A Systematic Review and Meta-Analysis

2026-06-15

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet their efficacy and safety in patients with chronic kidney disease (CKD) remain uncertain, as this population is frequently excluded from pivotal trials. We aimed to evaluate clinical outcomes of ICI therapy in patients with cancer and CKD. Methods We conducted a systematic review and meta-analysis comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56ed6e01-11a5-5bc7-ba1c-6de43b1c26de
DOI: 10.21203/rs.3.rs-10006164/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immune Checkpoint Inhibitors in Patients with Cancer and Chronic Kidney Disease: A Systematic Review and Meta-AnalysisDOI 10.21203/rs.3.rs-10006164/v1Read

Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: A retrospective studySemantic proximity Read

Soluble and cell-based markers of immune checkpoint inhibitor associated nephritisSemantic proximity Read

Adverse Renal Effects of Anticancer Immunotherapy: A ReviewSemantic proximity Read

Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in PolandSemantic proximity Read

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read

Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritisSemantic proximity Read

Clinical Features Associated with Immune Checkpoint Inhibitor Nephritis: A Single-Center Clinical Case SeriesSemantic proximity Read

Ketoanalogs supplementation not only retarded kidney function deterioration but also reversed adverse outcomes in patients with advanced chronic kidney disease in a nationwide studySemantic proximity Read

Efficacy and safety of anti-VEGF/VEGFR monotherapy and combination with immune checkpoint inhibitors for advanced or metastatic renal cell carcinoma: A network meta-analysisSemantic proximity Read

Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysisSemantic proximity Read

Molecular Insights into gene expression changes in apoptosis immune response and cellular regulation pathways in renal failure patientsSemantic proximity Read

Third-Line Treatment Options for Kidney Cancer.Semantic proximity Read